Simulations Plus, Inc. SLP 深滬

已收盤 02-06 16:00:00 美东时间

14.57

+0.430

+3.04%

華盛通

立即下載

最高14.71
今開14.25
成交量 27.20万股
最低 14.03
昨收 14.14
總市值 2.94亿
52周最高 37.55
市盈率 ^靜 --
換手率 1.35%
52周最低 12.39
委比 92.92%
總股本 2014.66万
歷史最高 90.08
量比 0.73
振幅 4.81%
歷史最低 0.47
每手 1
風險率 7.10%

個股概要

財務分析

公司資料

分紅派息

分時圖
日k
周k
月k

相關新聞

电话会总结｜ Simulations Plus(SLP)2026财年Q1业绩电话会核心要点

编者按：聚焦公司高管观点与展望，深挖业绩背后的信息，助力投资者把握先机。<blockquote>业绩回顾</blockquote>• 根据Simulations Plus业绩会实录，以下是财务业绩回顾摘要： ## 1. 财务业绩 **营收表现：** 第一季度总营收1,840万美元，同比下降3%，符合此前指引预期。软件营收占总营收48%，同比下降17%；服务营收占总营收52%，同比增长16%。 **盈利能力：** 调整后EBITDA为350万美元，符合管理层预期；调整后每股收益0.13美元，达到内部目标。总毛利率59%，其中软件毛利率84%，服务毛利率36%。 **现金状况：** 季末现金及短期投资3,570万美元，无债务负担，保持正向自由现金流。 **客户指标：** 季末商业客户3

01-16 12:16
美股大行评级 | 潜在涨幅197.4%！奥麦罗制药获HC Wainwright升目标价至40美元，维持"买入"评级

今日重点评级关注：HC Wainwright & Co.：维持奥麦罗制药"买入"评级，目标价从20美元升至40美元；HC Wainwright & Co.：维持Cullinan Therapeutics"买入"评级，目标价从26美元升至27美元

01-09 20:22
Simulations Plus Affirms FY2026 Adj EPS Guidance of $1.03-$1.10 vs $0.76 Est; Affirms FY2026 Sales Guidance of $79.000M-$82.000M vs $80.296M Est

Simulations Plus (NASDAQ:SLP) affirms FY2026 Adj EPS guidance from $1.03-$1.10 to $1.03-$1.10 vs $0.76 analyst estimate. Affirms FY2026 sales outlook from $79.000 million-$82.000 million to $79.000 million-$82.000

01-09 05:06
Simulations Plus Q1 Adj. EPS $0.17 Beats $0.13 Estimate, Sales $18.400M Beat $18.100M Estimate

Simulations Plus (NASDAQ:SLP) reported quarterly earnings of $0.17 per share which beat the analyst consensus estimate of $0.13 by 30.77 percent. This is unchanged from the same period last year. The company reported

01-09 05:06
TD Cowen Maintains Hold on Simulations Plus, Raises Price Target to $19

TD Cowen analyst Brendan Smith maintains Simulations Plus (NASDAQ:SLP) with a Hold and raises the price target from $16 to $19.

01-09 02:19
Earnings Scheduled For January 8, 2026

Companies Reporting Before The Bell • Acuity (NYSE:AYI) is projected to report ...

01-08 19:11
An Overview of Simulations Plus's Earnings

Simulations Plus (NASDAQ:SLP) is set to give its latest quarterly earnings repo...

01-07 22:01
BTIG Downgrades Simulations Plus to Neutral

BTIG analyst David Larsen downgrades Simulations Plus (NASDAQ:SLP) from Buy to Neutral.

2025-12-18 20:16
Simulations Plus Announces New Executive Appointments

Simulations Plus ( ($SLP) ) just unveiled an announcement. The news release fro...

2025-12-09 19:52
美股牛股 | 绩优股MongoDB大涨超22%，公司上调全年营收预测；Eventbrite飙升78.6%

绩优股MongoDB大涨超22%，公司上调全年营收预测；Eventbrite飙升78.6%，拟被5亿美元收购并私有化>>

2025-12-03 15:05

派息除權日	每股總股息	派息日期
2024-07-29	0.06	2024-08-05
2024-04-26	0.06	2024-05-06
2024-01-26	0.06	2024-02-05
2023-10-27	0.06	2023-11-06
2023-07-28	0.06	2023-08-07
2023-04-21	0.06	2023-05-01
2023-01-27	0.06	2023-02-06
2022-10-28	0.06	2022-11-07
2022-07-22	0.06	2022-08-01
2022-04-22	0.06	2022-05-02
2022-01-28	0.06	2022-02-07
2021-10-22	0.06	2021-11-01
2021-07-23	0.06	2021-08-02
2021-04-23	0.06	2021-05-03
2021-01-22	0.06	2021-02-01
2020-10-23	0.06	2020-11-02
2020-07-24	0.06	2020-08-03
2020-04-23	0.06	2020-05-01
2020-01-24	0.06	2020-02-03
2019-10-24	0.06	2019-11-01
2019-07-24	0.06	2019-08-01
2019-04-23	0.06	2019-05-01
2019-01-24	0.06	2019-02-01
2018-10-31	0.06	2018-11-08
2018-07-25	0.06	2018-08-02
2018-04-24	0.06	2018-05-02
2018-01-25	0.06	2018-02-02
2017-11-10	0.06	2017-11-20
2017-07-26	0.05	2017-08-04
2017-05-04	0.05	2017-05-15
2017-01-26	0.05	2017-02-06
2016-11-08	0.05	2016-11-17
2016-08-09	0.05	2016-08-18
2016-04-28	0.05	2016-05-09
2016-01-27	0.05	2016-02-05
2015-11-05	0.05	2015-11-16
2015-07-21	0.05	2015-07-30
2015-05-07	0.05	2015-05-18
2015-01-22	0.05	2015-02-02
2014-11-05	0.05	2014-11-14
2014-07-31	0.05	2014-08-11
2014-05-07	0.05	2014-05-16
2014-02-12	0.05	2014-02-24
2013-11-06	0.04	2013-11-15
2013-08-08	0.03	2013-08-15
2013-05-03	0.03	2013-05-10
2012-12-20	0.14	2012-12-28
2012-11-06	0.05	2012-11-13
2012-08-03	0.05	2012-08-10
2012-04-25	0.05	2012-05-08
2012-02-16	0.05	2012-03-01

公司名稱	Simulations Plus, Inc.
行業分類	医疗保健软件
業務描述	Simulations Plus, Inc. engages in the provision of software and consulting services supporting drug discovery, development, research, clinical trial operations, regulatory submissions, and commercialization. The firm operates through the Software and Services segment. The Software segment offers software products for pharmaceutical research, development, and commercialization of the firm's products. The Services segment focuses on contracted consulting studies for customers and offers services supporting marketplace insight and medical communications for clinical and commercial drug development. The company was founded by Walter S. Woltosz and Virginia E. Woltosz on July 17, 1996 and is headquartered in Durham, NC.

Simulations Plus, Inc. SLP 深 滬

14.57

個股概要

財務分析

公司資料

相關新聞

分紅派息

相關新聞

公司簡介

Simulations Plus, Inc. SLP 深滬